1. Home
  2. TPR vs UTHR Comparison

TPR vs UTHR Comparison

Compare TPR & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPR
  • UTHR
  • Stock Information
  • Founded
  • TPR 1941
  • UTHR 1996
  • Country
  • TPR United States
  • UTHR United States
  • Employees
  • TPR N/A
  • UTHR N/A
  • Industry
  • TPR Apparel
  • UTHR Biotechnology: Pharmaceutical Preparations
  • Sector
  • TPR Consumer Discretionary
  • UTHR Health Care
  • Exchange
  • TPR Nasdaq
  • UTHR Nasdaq
  • Market Cap
  • TPR 17.5B
  • UTHR 14.4B
  • IPO Year
  • TPR 2000
  • UTHR 1999
  • Fundamental
  • Price
  • TPR $98.32
  • UTHR $297.02
  • Analyst Decision
  • TPR Buy
  • UTHR Buy
  • Analyst Count
  • TPR 18
  • UTHR 13
  • Target Price
  • TPR $85.11
  • UTHR $383.08
  • AVG Volume (30 Days)
  • TPR 3.8M
  • UTHR 551.5K
  • Earning Date
  • TPR 08-14-2025
  • UTHR 07-30-2025
  • Dividend Yield
  • TPR 1.42%
  • UTHR N/A
  • EPS Growth
  • TPR 0.55
  • UTHR 18.86
  • EPS
  • TPR 3.79
  • UTHR 25.10
  • Revenue
  • TPR $6,878,600,000.00
  • UTHR $2,994,100,000.00
  • Revenue This Year
  • TPR $5.39
  • UTHR $14.30
  • Revenue Next Year
  • TPR $2.15
  • UTHR $6.32
  • P/E Ratio
  • TPR $25.98
  • UTHR $11.79
  • Revenue Growth
  • TPR 2.67
  • UTHR 19.84
  • 52 Week Low
  • TPR $35.23
  • UTHR $266.98
  • 52 Week High
  • TPR $98.61
  • UTHR $417.82
  • Technical
  • Relative Strength Index (RSI)
  • TPR 79.00
  • UTHR 51.32
  • Support Level
  • TPR $84.39
  • UTHR $286.68
  • Resistance Level
  • TPR $89.18
  • UTHR $301.75
  • Average True Range (ATR)
  • TPR 2.44
  • UTHR 6.73
  • MACD
  • TPR 1.01
  • UTHR 1.81
  • Stochastic Oscillator
  • TPR 98.82
  • UTHR 77.16

About TPR Tapestry Inc.

Based in New York City, Tapestry is the parent company of accessories and fashion brand Coach, which accounts for about 80% of its sales and more than 90% of its operating profit. Coach products are sold through 900 company-owned stores, e-commerce, and third-party stores in North America, Asia, and Europe. Tapestry also owns Kate Spade, which generated 54% of its sales from handbags in fiscal 2024. Kate Spade is known for its colorful patterns and graphics. Meanwhile, Tapestry's smallest brand, luxury footwear maker Stuart Weitzman, is set to be sold to Caleres in the summer of 2025.

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

Share on Social Networks: